1. Introduction {#sec0005}
===============

1.1. Rationale {#sec0010}
--------------

Flinders Technology Associates (FTA) cards® have been widely used for DNA preservation and analysis, particularly in forensic sciences and genetic studies ([@bib0080]; [@bib0260]). This technology consists of filter paper impregnated with a patented chemical mixture that contains chemical denaturants and a free radical scavenger. The chemical mixture lyses cells and organelles, prevents overgrowth of bacteria, and denatures proteins. The DNA is captured in the matrix and remains tightly bound while proteins and inhibitors are washed. This keeps DNA stable during long-term storage at room temperature ([@bib0060]).

This method is attractive for several applications, including research of bacterial genetics, as DNA can be maintained at ambient temperature ([@bib0240]). FTA cards® have also been used for storing samples and molecular detection of both DNA and RNA viruses. Recently, they have been proposed as an alternative to liquid media in the screening of cervical cancer for HPV detection ([@bib0040]), and improved biosafety has been cited as an advantage in the storage and transport of specimens containing avian influenza virus ([@bib0105]). However, viral RNA is an unstable molecule, susceptible to ubiquitous RNases, complicating its transport and detection.

This challenge is particularly relevant in settings where proper technical support for RNA handling may not be available (hereafter referred to as fieldwork). Although some studies have evaluated the FTA® cards for viral RNA preservation ([@bib0220]; [@bib0205]; [@bib0050]), the optimal conditions for their handling have not been extensively studied. Notwithstanding, it is crucial to determine the appropriate temperature and maximum time for storing RNA samples on FTA cards, as well as their biosafety, in order to fieldwork with these pathogens.

1.2. Objectives {#sec0015}
---------------

In this context, this systematic review aims to assess published studies that used FTA cards® as a mean for viral RNA preservation before molecular detection.

2. Methods {#sec0020}
==========

2.1. Literature search {#sec0025}
----------------------

For conducting this systematic review, we followed the recommendations of the PRISMA statement ([@bib0185]). In June 2018, MEDLINE (PubMed), Scopus and Science Citation Index (Web of Knowledge) were searched to identify potentially relevant articles using the search strategy ("FTA cards" AND "RNA"). No limit was set for the year, and only articles published in English or Spanish were assessed. The references of the included articles were also reviewed looking for eligible articles.

2.2. Study eligibility and selection {#sec0030}
------------------------------------

Two different authors conducted the review independently, and it was completed on July 1^st^, 2018. The resulting articles were initially selected by title and abstract to identify possibly eligible studies according to the selected criteria. Subsequently, duplicates were excluded, and two authors reviewed full-text of the eligible articles. When there was disagreement in the inclusion of a study, a third researcher made the final decision. We assessed studies that used FTA cards® for storage and later isolation of RNA of viral origin with subsequent amplification. Different conditions of storage, RNA extraction, or cDNA synthesis were separately summarized when the information was available. We excluded opinion articles, letters to the editor that did not present original data, reviews, as well as articles for which full-text was not accessible through our institutional subscriptions or their information was incomplete. The potentially eligible articles were entered in a database, screened based on title and abstract and reviewed independently by two research team members. Articles included in the review by either team member were submitted to full-text screening.

2.3. Data extraction {#sec0035}
--------------------

Data extraction was performed by a third author not involved in screening and selection. The data extracted were: author, title, year of the study, institution, source of sample (e.g. blood, serum, plasma, allantoic fluid, other tissues), origin of the sample (i.e. human, poultry, plants), method of extraction of RNA from the FTA card®, time and temperature of storage of FTA card, method of assessment of RNA integrity and purity, and amplification method of the viral genome fragment.

For studies that addressed different storage times, temperatures and amplicon sizes, the maximum time and maximum temperature at which the viral RNA was detectable as well as the largest amplicon size (bp) reported were recorded. Elution characteristics were compiled if RNA extraction was conducted through elution. If the study assessed the infectivity of the virus isolated from the FTA card®, it was included.

2.4. Quality assessment {#sec0040}
-----------------------

Because there is not a previously validated tool for assessment of the quality of studies assessing methods for sample preservation on FTA cards®, we built a checklist consisting of ten criteria that were scored using a discrete scoring. Each item was scored with 2 = if the information provided was complete or sufficient to replicate the methods, 1 = if the information was incomplete or unclear, or 0 = if no information was provided. For data visualization a heatmap was generated using the scores.

The included items were: 1. Source of the sample: Report of the kind of sample obtained for storage in a FTA card®. 2. Time of storage: Report of the time the FTA card® was stored between sample collection and FTA card® processing for RNA isolation and RT-PCR. 3. Temperature of storage: Report of the temperature at which the FTA card® was stored. 4. Amplicon size: Report of the size (bp) of the targeted viral gene for amplification. If the work tried complete genome sequencing the answer to this question was also scored with two. 5. Extraction method: specification with precise detail to guarantee the reproducibility of the methods used for RNA extraction from the FTA card®. 6. Purification method: Specific information to assure the reproducibility of the methods used for RNA purification. 7. cDNA synthesis conditions: enough information about reagents and conditions to ensure the reproducibility of the methods for cDNA synthesis, including primers and cycling conditions. 8. PCR conditions: enough information concerning the methods and reagents used for PCR, including primers and cycling conditions. 9. Quantification of RNA copies: Report of quantification through RT-qPCR of the RNA isolated from the FTA card®. 10. Sequencing: Report about the sequencing of the desired amplicon and confirmed identity of the targeted virus, or confirmation through whole-genome sequencing with next-generation sequencing techniques (NGS).

2.5. Assessment of RNA isolation and definition of viral non-infectiousness {#sec0045}
---------------------------------------------------------------------------

Experiments of viral RNA detection from FTA cards® were considered successful if the RNA fragment of interest was finally amplified from cDNA (Retro-transcription, RT) and PCR irrespective of the fragment size or if the RNA isolation allowed further genome sequencing through NGS. For studies assessing infectivity, we considered FTA card® specimens to be noninfectious when virus isolation was negative through cell culture or bio-assays using material obtained of the cards.

3. Results {#sec0050}
==========

We found 175 records using the search strategy, and 11 additional records by checking references of the included articles. After title and abstract screening, 44 articles were excluded because they were duplicates, and 108 papers were selected for screening by title and abstract. After the examination of exclusion criteria, a total of 47 articles were finally included ([Fig. 1](#fig0005){ref-type="fig"} ). All the included articles were published in English, and all of them achieved viral RNA amplification. The assessment of the quality of the information in each article is shown in [Fig. 2](#fig0010){ref-type="fig"} .Fig. 1PRISMA 2009 Flow Diagram of retrieved and selected articles during the systematic review.Fig. 1Fig. 2Quality assessment chart. Each included study was assessed in order to determine the information provided for each variable. Each variable was scored with 2 = green, if the information provided was complete or sufficient to replicate the methods, 1 = yellow, if the information was incomplete or unclear, or 0 = red, if no information was provided. For data visualization a heatmap was generated using the scores (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).Fig. 2

A total of 95.7% of the included studies extracted total RNA before targeted amplification of the viral RNA, while the 4.3% directly isolated viral RNA from the FTA card. The studies used a wide variety of sources and samples, which included samples from mammals, birds, insects, plants, cells, and humans ([Table 1](#tbl0005){ref-type="table"} ). The targeted viral genomes belonged to all classes of RNA virus of the Baltimore Classification except Class VI, with 8.5% of the studies reporting amplification of RNA fragments of Class III virus (dsRNA), 68.1% of Class IV virus ((+) ssRNA), 21.3% of Class V virus ((−) ssRNA), and 2.1% of the three classes mentioned above. An animal specimen source accounted for 38.3% of the reports ([@bib0200]; [@bib0175]; [@bib0195]; [@bib0225]; [@bib0235]; [@bib0085]; [@bib0210]; [@bib0005]; [@bib0105]; [@bib0100]; [@bib0115]; [@bib0120]; [@bib0010]; [@bib0020]; [@bib0055]; [@bib0090]; [@bib0125]; [@bib0170]). Among them, twelve reports isolated RNA from viruses that can cause disease in poultry or wild birds, like Newcastle virus disease, avian influenza, or infectious bursal disease ([Table 1](#tbl0005){ref-type="table"}). Six reports isolated RNA of viruses that can cause disease in suids or bovids, like respiratory syndrome virus, and foot-and-mouth disease virus ([Table 1](#tbl0005){ref-type="table"}).Table 1General characteristics of the included works that performed viral RNA amplification/sequencing from samples immobilized in FTA cards®. N/A = Not Apply, (−) = Information not provided.Table 1StudyYearInstitutionRNA sampleSourceRNA isolatedVirusViral genomeInfectivityMaximum time of storageTemperature of storageExtraction methodRT-PCR methodPrimer strategy (RT)Bankamp B, et al..2013Centers for Disease Control and PreventionVero/hSLAM cellsCellsTotalMeasles morbillivirusssRNA(−)--6 months4 °CElutionone step RT-qPCRSpecificMuthukrishnan M, et al.2008Indian Immunologicals LimitedBHK21 cellCellsTotalFoot-and-mouth disease virusssRNA(+)No120 daysRoom temperatureDisc cleaningone step RT-qPCRSpecificElutionone step RT-qPCRSpecificManswr B, et al.2018University of LiverpoolAllantoic fluidAnimalTotalInfectious bronchitis virusssRNA(+)--21 daysRoom temperatureElutiontwo step RT-PCRSpecificUniversity of LiverpoolAllantoic fluidAnimalTotalInfectious bronchitis virusssRNA(+)--21 daysRoom temperatureElutiontwo step RT-PCRSpecificMoscoso H, et al.2006The University of GeorgiaBursal tissueAnimalTotalInfectious bursal disease virusdsRNA--8 months−20 °CElutionone step RT-PCRSpecificChang PG, et al.2011Virginia Polytechnic Institute and State UniversityLeafPlantTotalTobacco etch virus, Soybean mosaic virus, Turnip mosaic virus, Cucumber mosaic virus, and Peanut stunt virusssRNA(+)------Disc cleaningtwo-step RT-PCRSpecificLinhares DC, et al2012College of Veterinary MedicineSerum and lungAnimalTotalPorcine reproductive and respiratory syndrome virusssRNA(+)--14 daysRoom temperatureElutionone step RT-PCRSpecificMaina S, et al.2017University of Western AustraliaLeafPlantTotalCucurbit aphid-borne yellows virusssRNA(+)----N/SPurificationRNA-seq--Madhanmohan M, et al.2013Indian Immunologicals LimitedTongue epitheliumAnimalTotalFoot-and-mouth disease virusssRNA(+)--1 month25 °CPurificationRT-LAMPSpecificNavaneeth Krishnan A, et al.2016Central Institute of Brackishwater AquacultureLarval homogenate, cell culture extract, milt extract, seawater spiked with larval homogenateAnimalTotalBetanodavirus spp.ssRNA(+)--28 days4 °CPurificationone step RT-PCRSpecificMelanson VR, et al.2017United States Army Research Institute of Infectious DiseasesAe. aegypti salivaInsectTotalDengue virusssRNA(+)--------one step RT-PCRSpecificMaina S, et al.2018The University of Western AustraliaLeafPlantTotalSweet potato feathery mottle virus and Sweet potato virus CssRNA(+)------Purificationone step RT-PCRSpecificFlies EJ, et al.2015University of TasmaniaMosquito salivaInsectTotalArbovirus (Ross River virus, Barmah Forest virus, and Stratford virus)ssRNA(+)--Seven days25 °CElutiontwo-step RT-PCRSpecificGrund E, et al.2010University of HamburgLeafPlantTotalWatermelon chlorotic stunt virus, Mycovirus China 9, Tomato spotted wilt virus, Tobacco mosaic virus, Cucumber mosaic virus, Little cherry virus 1, Little cherry virus 2, Potato spindle tuber viroiddsRNA, ssRNA(+), ssRNA(−)------Elutiontwo-step RT-PCRSpecificYang Y, et al.2015Walter Reed Army Institute of ResearchBloodInsectTotalDengue virus type 2ssRNA(+)--1 monthRoom temperatureElutionone step qRT-PCR, MiSeqSpecific and randomAbdelwhab EM, et al2011Free Berlin UniversityAmnio-allantoic fluidAnimalTotalAvian influenza virusssRNA(−)No5 monthsRoom temperatureElutionone step RT-qPCRSpecificLi Y, et al.2012Shandong Center for Disease Control and PreventionHEp-2 CellsCellsTotalEnterovirus spp.ssRNA(+)------Elutionone step qRT-PCROligo dT and Random primersKeeler SP, et al2012The University of GeorgiaCloacal swabsAnimalTotalAvian influenza virusssRNA(−)--90 daysRoom temperatureElutionone step RT-PCRSpecificKraus RH, et al2011Wageningen UniversityCloacal swabsAnimalTotalAvian influenza virusssRNA(−)--N/S--Elutionone step RT-PCRSpecificSakai T, et al2015Nihon University Veterinary Research CenterVaccineVaccineViralRabies virusssRNA(−)--4 months−20 °CElutionone step RT-PCRSpecificMaw MT, et al2006United Graduate School of Veterinary SciencesMucoseAnimalTotalInfectious bursal disease virusdsRNAYes30 days37 °CElutiontwo-step RT-PCRSpecificPurvis LB, et al2006University of GeorgiaBursal tissueAnimalTotalInfectious bursal disease virusdsRNA--24 hoursRoom temperatureElutionone step RT-PCRSpecificBiswal JK, et al2016ICAR- Directorate on Foot-and-mouth DiseaseClinical samples (cell culture isolates, tongue epithelial suspension, and impression smears)AnimalTotalFoot-and-mouth disease virusssRNA(+)--6 weeks4-37 °CElutiontwo-step RT-PCROligo dTPrice JA, et al.2014Texas A&M AgriLife Research and ExtensionWheat curl miteAnimalTotalWheat streak mosaic virusssRNA(+)--1 hourRoom temperatureElutionone step RT-PCRSpecificMoscoso H, et al.2005The University of GeorgiaAllantoic fluidAnimalTotalInfectious bronchitis virusssRNA(+)--36 daysRoom temperatureElutionone step RT-PCRSpecificKaravina C, et al2017University of KwaZulu-NatalLeafPlantTotalTomato spotted wilt virusssRNA(−)------Elutiontwo step RT-mPCRSpecificTam KI, et al2015Centers for Disease Control and PreventionStoolHumanTotalRotavirus AdsRNA--28 days37 °CElutionone step RT-PCRSpecificRoy Y, et al.2005University of GuelphLeaf and fruitPlantTotalPepino mosaic virus and Rupestris stem pitting associated virusssRNA(+)--8 monthsRoom temperatureDisc cleaningone step RT-PCRSpecificAwad F, et al.2014University of LiverpoolTracheal organ culturesAnimalTotalAvian metapneumovirusssRNA(−)No2 months4 °CPurificationRT-PCRSpecificNarayanan MS, et al.2010Madras veterinary collegeAllantoic fluidAnimalTotalAvian avulavirus 1ssRNA(−)No20 days4 °CDisc cleaningtwo-step RT-PCRSpecificNdunguru J, et al.2005International Laboratory of Tropical Agriculture BiotechnologyLeafPlantTotalGeminivirusssRNA(+)----N/SElutiontwo step RT-PCRSpecificDauner AL, et al.2015Naval Medical Research CenterBloodHumanTotalDengue virusssRNA(+)--21 days37 °CElutionone step RT-PCRSpecificMadhanmohan M, et al.2016Indian ImmunologicalsSmearAnimalTotalFoot-and-mouth disease virusssRNA(+)No56 days4 °CElutionone step RT-PCRSpecificJozwiak M, et al.2016National Veterinary Research InstituteAllantoic fluidAnimalTotalAvian influenza virusssRNA(-)No90 daysRoom temperature--one step RT-PCRSpecificMontmayeur AM, et al.2017Centers for Disease Control and PreventionPoliovirus cultureVirusViralPoliovirusssRNA(+)------PurificationNGS sequencingRandomFoss L, et al.2016California Department of Public HealthOral swabsAnimalTotalWest Nile virusssRNA(+)------Elutionone step RT-PCRSpecificInoue R, et al.2007Kyoto Prefectural UniversityBloodAnimalTotalPorcine reproductive and respiratory syndrome virusssRNA(+)------Disc cleaningone step RT-PCRSpecificHall-Mendelin S, et al.2017Public Health VirologyMosquito salivaAnimalTotalArbovirus (Zika virus, Chikungunya virus, Dengue virus, and Barmah Forest virus)ssRNA(+)--28 daysRoom temperatureElutionone step RT-PCRSpecificPerozo F, et al2006University of GeorgiaAllantoic fluidAnimalTotalNewcastle disease virusssRNA(−)No15 daysRoom temperaturePurificationone step RT-PCRSpecificHall-Mendelin S, et al.2010University of QueenslandMosquito salivaAnimalTotalArbovirus (West Nile river, Ross River virus, and chikungunya virus)ssRNA(+)--28 days23 °CElutionone step RT-PCRSpecificMaina S, et al.2017University of Western AustraliaLeafPlantTotalAphid lethal paralysis virusssRNA(+)------PurificationSequencing (metagenomic)N/AMaina S, et al.2016University of Western Australia--PlantTotalSweet potato chlorotic fleck virusssRNA(+)------PurificationGenome sequencingN/AMaina S, et al.2016University of Western Australia--PlantTotalSweet potato virus 2ssRNA(+)------PurificationGenome sequencingN/AMaina S, et al.2016University of Western AustraliaLeafPlantTotalSuakwa aphid-borne yellows virusssRNA(+)------PurificationGenome sequencingN/AMaina S, et al.2016University of Western AustraliaLeafPlantTotalBean common mosaic necrosis virusssRNA(+)------PurificationGenome sequencingN/AMaina S, et al.2016University of Western Australia--PlantTotalSweet potato virus GssRNA(+)------PurificationGenome sequencingN/AMaina S, et al.2017University of Western AustraliaLeafPlantTotalPapaya ringspot virus biotype WssRNA(+)------Purificationtwo step RT-PCR, RNA-seqSpecificChikh-Ali M, et al2016University of IdahoLeafPlantTotalPotato virus YssRNA(+)------Elutiontwo step RT-PCRSpecific[^1]

Plant samples were assessed in 31.9% of the included articles, and samples obtained from insects corresponded to 14.9%. These works aimed to amplify viral RNA of arboviruses that can cause disease in humans, and also viruses capable of causing disease in fishes and plants ([@bib0075]; [@bib0230]; [@bib0050]; [@bib0270]; [@bib0215]; [@bib0070]; [@bib0180]; [@bib0030]). Viral specimens were derived from cell culture or from a commercial inactivated vaccine in 10.6% of the reports ([@bib0205]; [@bib0110]; [@bib0015]; [@bib0250]; [@bib0190]). Finally, two reports isolated virus using human samples: stool and blood. ([@bib0035]; [@bib0265]).

Infectious virus was isolated from one of only fourteen included studies that tested for infectivity of the virus from an FTA card® ([@bib0175]). In this study, ADVANTEC chromatography paper No. 526, (Toyo Roshi, Tokyo, Japan), ADVANTEC filter paper No. 2 (Toyo Roshi), and stationery copy paper were compared with FTA cards® for the isolation and inactivation of the dsRNA from the infectious bursal disease virus, a virus member of the *Birnaviridae* family, genus *Avibirnavirus*, with a segmented genome. In this study, every paper-based matrix allowed the isolation of viral RNA and infectious virus. However, virus inactivation was achieved after phenol fixation on the FTA card®. Thirteen other studies demonstrated a lack of infectious virus from the FTA card ([@bib0200], [@bib0195], [@bib0225], [@bib0205], [@bib0210], [@bib0005], [@bib0100], [@bib0115], [@bib0015], [@bib0010], [@bib0265], [@bib0090], [@bib0125]) when examining (-) ssRNA viruses of the families *Paramyxoviridae* (Newcastle disease virus, genus *Avulavirus, Measles morbillivirus, subfamily Orthoparamyxovirinae*, genus *Morbillivirus*), *Orthomyxoviridae* (Avian influenza virus, genus *Alphainfluenzavirus*), and *Pneumoviridae* (*Avian metapneumovirus*, genus *Metapneumovirus*), (+) ssRNA virus members of the family *Picornaviridae* (Foot-and-mouth disease virus, genus *Aphthovirus*), *Arteriviridae* (Porcine reproductive and respiratory syndrome virus), and *Coronaviridae* (Avian coronavirus, genus *Gammacoronavirus*), and dsRNA virus of the family *Birnaviridae* (Infectious bursal disease virus, genus *Avibirnavirus*) and *Reoviridae* (Rotavirus A, genus Rotavirus). These studies attempted viral isolation from FTA cards impregnated with infected material using cell culture ([@bib0195], [@bib0205], [@bib0100], [@bib0115], [@bib0015], [@bib0010], [@bib0265], [@bib0125]), bioassays infecting specific pathogen-free embryonated chicken eggs ([@bib0200], [@bib0225], [@bib0005], [@bib0090]) or both ([@bib0210]).

Regarding storage of the FTA cards® before further viral RNA purification, the cards were stored for periods that varied from one to eight months (median time: 30 days, IQR 21--90), at temperatures that ranged between −20 °C to 37 °C (median temperature: 25 °C, IQR 4 °C--25 °C). Three protocols for RNA amplification from the FTA card® were reported: 1. Elution of RNA from the FTA card®, 2. Direct viral RNA purification, and 3. Disk cleaning and soaking.

Elution of RNA from FTA cards® before RNA amplification was the most common method for RNA extraction. It was performed in 55.1% of the assessed studies. The elution conditions and eluents used in those studies are summarized in [Table 2](#tbl0010){ref-type="table"} . Briefly, viral RNA was obtained by soaking fragments of the FTA card® in an eluent solution, followed by incubation with or without agitation with temperatures that ranged between 4--95 °C. After elution, the RNA underwent a purification step using commercial kits ([@bib0200]; [@bib0220]; [@bib0175]; [@bib0195]; [@bib0235]; [@bib0005]; [@bib0100]; [@bib0110]; [@bib0015]; [@bib0250]; [@bib0265]; [@bib0270]; [@bib0020]; [@bib0055]; [@bib0125]; [@bib0095]; [@bib0170]) or standard protocols like sodium acetate and isopropanol precipitation ([@bib0065]; [@bib0230]). In one case, magnetic beads were used for purification and concentration of RNA ([@bib0115])Table 2Characteristics of studies that performed RNA elution from FTA cards® before RT-PCR reaction. (-) Not performed.Table 2StudyEluentElution volume (μL)Elution time (min)AgitationElution temperaturePurification methodBankamp B, et al.PBS + AVL buffer75010--Room temperatureQIAamp Viral RNA Mini KitManswr B, et al.TE buffer100015--Room temperatureQIAamp viral RNA Mini KitTE buffer100015--Room temperatureQIAamp viral RNA Mini KitMoscoso H, et al.Tris-HCl + EDTA20010--Room temperatureHigh Pure Viral RNA KitLinhares DC, et al.RNA rapid extraction solution1005--Room temperatureMagnetic bead-based technologyFlies EJ, et al.GM + 3%FBS100020Vortex every 5minOn iceEZ1 Virus Mini 109 Kit v2.0 (Qiagen, Victoria, AU)Grund E, et al.Elution buffer40015Agitation every 5min4 °CSodium acetate and isopropanol precipitationYang Y, et al.AVL buffer + RNA carrier5665Continuous vortex +5 min centrifugationRoom temperatureQiagen QIAamp Viral RNA kitAbdelwhab EM, et alTE buffer20010--Room temperatureQiagen Viral RNA Mini KitLi Y, et al.Deionized sterile water + TE-1 + Tris--HCl + Buffer EB (Tris--Cl, elution buffer from the QIAamp Viral RNA Mini Kit)3040Vortex at 100x during 30 min, 10 min vortex at 200xg in intervals of 1 min65 °C or 95 °CRoche Pure Viral RNA kitKeeler SP, et al.RNA rapid extraction solution7560--Room temperatureMagMAX™-96 AI/ND Viral RNA Isolation KitRNA rapid extraction solution7560--Room temperatureMagMAX™-96 AI/ND Viral RNA Isolation KitKraus RH, et al.RNA rapid extraction solution705AgitationRoom temperatureMagMAX-96 viral RNA isolation kitSakai T, et al.Nuclease-free water1501440--Room temperatureQIAamp® Viral RNA Mini KitTE buffer1501440--Room temperatureQIAamp® Viral RNA Mini KitRNA rapid extraction solution15030--Room temperatureQIAamp® Viral RNA Mini KitTRIzol Reagent15030--Room temperatureQIAamp® Viral RNA Mini KitAVL buffer1501440--Room temperatureQIAamp® Viral RNA Mini KitMaw MT, et al.Nuclease-free water755AgitationRoom temperatureTRIzol ReagentPurvis LB, et al.Whatman purification reagent20020Vortex every 5minRoom temperatureHigh Pure RNA isolation kitBiswal JK, et al.AVL buffer56010--Room temperatureQIAmp Viral RNA mini kitPrice JA, et al.TE buffer40015Vortex every 5minIce incubationSodium acetate and isopropanol precipitationMoscoso H, et al.Tris-HCl and EDTA20010--Room temperatureHigh Pure Viral RNA KitKaravina C, et al.Nuclease-free water5030Vortex 15 seg95 °C--Tam KI, et al.TE buffer400240--Room temperatureMagMAX™ Viral RNA isolation kitNdunguru J, et al.RNA processing buffer (10 mM Tris-HCl, pH 8.0, 0.1 mM EDTA, 800 U/mL RNase Out™ 200--250 μg/mL glycogen and 2 mM DTT)50030Vortex every 5minRoom temperatureSodium acetate and isopropanol precipitationDauner AL, et al.AVL buffer30060ShakingRoom temperatureQIAamp viral RNA Mini KitMadhanmohan M, et al.VMM460900--4 °CRNeasy® Mini KitFoss L, et al.ABI Magmax lysis binding solaution1000900--Room temperature--Hall-Mendelin S, et al.GM + 3%FBS100020Vortex every 5minOn iceQIAamp® Virus BioRobot® MDx KitHall-Mendelin S, et al.GM + 3%FBS100020Vortex every 5minOn iceQIAamp® Virus BioRobot® MDx KitChikh-Ali M, et alRNA processing buffer50030Vortex every 5minRoom temperatureSodium acetate and isopropanol precipitation

Direct virus RNA purification was performed in 30.6% of the studies. It consisted of a protocol in which FTA card® punches were used for RNA purification without a previous step of elution from the FTA card®. The punches were directly soaked in the lysis and extraction solutions of different commercial kits, TRIzol reagent® or Guanidinium thiocyanate-phenol-chloroform method ([Table 1](#tbl0005){ref-type="table"}). Most of the studies used methods for total RNA extraction and only one study used a commercial kit for viral RNA isolation ([@bib0190]). In this particular case, the genome of polioviruses, (*Enterovirus C*, genus *Enterovirus*, family *Picornaviridae*), a virus with a (+) ssRNA non-segmented genome of 6.7--10.1 kb with a poly(A) tail, was isolated from FTA cards®. This method allowed the use of NGS techniques for complete genome sequencing with a total of 206,156 reads (90% of reads mapping to poliovirus, giving 99% genome coverage) ([@bib0190]).

On the other hand, 8.2% of the included studies used disk cleaning and soaking for RNA purification, which consisted of punching a disk from the card and placing in a solution to remove contaminants before proceeding one or two-step RT-PCR by placing the cleaned disk into a second solution (the reaction mix). Note that this method did not include an RNA purification step ([@bib0245]; [@bib0085]; [@bib0210]; [@bib0025]).

The third strategy was to perform one or two-step RT-PCR after RNA isolation or preparation from the FTA cards®. In 57.1% of these studies, the targeted viral genes were amplified by one-step RT-PCR. Most of them (96.4%) used specific primers for the RT step and the PCR step. Only one study used random primers for RT and then specific primers for PCR ([@bib0270]). The reaction mix composition, as well as the cycling conditions in each work, varied depending on the PCR kit used and the desired amplicon. Eleven studies quantified the product of the RT-PCR, 26 used the product of these reactions for sequencing, and in one study, RNA-seq was implemented for viral identification. ([@bib0135],[@bib0145],[@bib0140],[@bib0150],[@bib0155]; [@bib0130], [@bib0160]; [@bib0165]; [@bib0190]).

4. Discussion {#sec0055}
=============

The findings of this systematic review support that viral RNA from different types of RNA viruses spotted in a FTA card® can be purified and then amplified for viral identification. The RNA can be isolated from a large number of sources and samples, and stored over a wide range of periods of time and temperatures. This highlights the fact that FTA cards® could be used as means for transport and storage of RNA pathogens. However, storage time and temperature are critical variables affecting RNA preservation. Studies reviewed here suggest that viral RNA could be stable in a wide range of temperatures for several months. Cards stored at 4 °C allowed the amplification of fragments up to ˜1200 bp, and cards stored for six months allowed amplification of fragments up to ˜800 bp.

Use of FTA cards to work with biospecimens appears to be relatively safe since isolation of infectious virus was rarely reported. Nevertheless, the possibility remains that some infectious virus could be present in this type of sample, as shown by the study of bursal disease virus. In this case, additional chemical fixation was used to render the sample completely noninfectious ([@bib0175]).

More data is required to explain why the bursal disease virus remained infectious when such a wide variety of viruses were inactivated after spotting on FTA cards® ([@bib0225]; [@bib0210]; [@bib0005]; [@bib0010]; [@bib0090]; [@bib0125]). Possible explanations include that infectious bursal disease virus is a non-enveloped virus. While enveloped viruses can persist viable in dried surfaces for five days, non-enveloped viruses can persist for weeks ([@bib0045]). However, the inability to isolate viable foot-and-mouth disease virus from FTA cards®, another non-enveloped virus, is inconsistent with this argument ([@bib0125]). Storage time and temperature and card manipulation and processing during viral isolation are other possible factors that could affect viral infectiousness. It is remarkable that [@bib0175] isolated infective virus after seven days of storage at room temperature, but [@bib0090] were unable of performing viral isolation even as earlier as 1 h after sample spotting on FTA card, and [@bib0115] after storage at 4 °C for 24 h. In this context, viral viability testing after immobilization on FTA cards® seems like an advisable practice before considering FTA cards® isolates innocuous. Then, FTA cards® should be managed and stored following the required biosafety precautions.

Different methods for extraction and purification were represented in the literature. The elution and subsequent purification of the RNA are the most widely used, and different elution solutions in a wide range of volumes, time, agitation and temperatures have been tested. Based on these protocols, we advise to keep the elution volume below 500 μL and the elution time below 30 min, with vortex or agitation every 5 min at room temperature. Then perform RNA purification using commercial kits or standard protocols before subsequent RT-PCR. This method was effective for amplification of fragments up to ˜1700 bp.

For disc cleaning protocols it is advisable to add 200 μL of FTA purification reagent in a tube containing the discs, mix thoroughly for 3 min at room temperature, and repeat this step twice. Then, rinse the discs with 200 μL of TE Buffer and, finally, add the disc to the proper PCR reaction mix. When the source material likely contains PCR inhibitors, an additional step of cleaning with 200 μL of Ethanol 70% can be performed ([@bib0245]; [@bib0085]; [@bib0210]; [@bib0025]). These protocols and direct purification protocols allowed amplification of fragments of ˜900 bp, even when the storage times of the FTA card® were up to eight months at room temperature. This suggests that probably the three reported methods for RNA extraction from the FTA card® have similar effectiveness and that their selection could be related to reagent availability or personal preferences.

4.1. Limitations {#sec0060}
----------------

Since the stability and integrity of viral RNA for molecular detection is a significant concern during fieldwork, this systematic review focused on the evaluation of FTA cards® as a strategy for detection of these pathogens. However, successful applications of these cards have been also reported for DNA viruses and bacteria ([@bib0040]; [@bib0240]). For instance, the use of FTA cards® have been proved effective as a means of sample storage and transport for genotyping isolates of *Campylobacter jejuni* obtained from poultry and stored for three months at room temperature ([@bib0255]).

It is possible that publication bias, the lack of publishing reports with negative results, could lead to failure in identifying studies that were unable to amplify RNA extracted from the FTA cards®. The search strategy ("FTA cards" AND "RNA") was used instead of ("FTA card" AND "RNA") since the first retrieved more records in two of the assessed databases, and the same number of records in Scopus. Additionally, though we conducted an extensive search in different databases, and the screened works were searched through different institutional subscriptions, four papers were not accessible for full-text assessment. Nevertheless, the search identified more than forty reports evaluating FTA cards® as RNA immobilization matrix with sufficient information to summarize their protocols for potential replication.

Although the goal of this review was to consider fieldwork conditions, some of the identified studies used the FTA card® for RNA spotting in controlled laboratory conditions. Therefore, the effectiveness of this matrix could vary when used in fieldwork and associated handling and shipping conditions. In these particular cases, fieldwork testing should be performed. However, some of the studies identified tested their effectiveness submitting these matrices to transport and shipping, similar to fieldwork conditions ([@bib0125]).

5. Conclusions {#sec0065}
==============

The effectiveness of FTA cards® for sample collection and recovery of viral RNA for downstream analysis was demonstrated by several studies. Use of FTA cards® may be an attractive approach for fieldwork involving molecular detection and/or characterization of viral pathogens, particularly when simple and cheap sample collection and transport systems are desirable. The stability of RNA genomic material of many different viruses under a wide range of conditions further supports the advantage of FTA cards® use, even for metagenomic analysis ([@bib0270]; [@bib0160]). Though many viruses will become inactivated in the collection and storage process, we suggest that all specimens should be considered potentially infectious unless proven otherwise. Thus, the available evidence suggests that FTA cards® are a good option for virus storage and transport for molecular detection and identification of RNA viral pathogens, although additional field testing would be advisable to further validate and standardize these methods for use in the fieldwork.
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[^1]: LAMP = Loop-mediated Isothermal Amplification.
